StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)

Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –

Elevance Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Elevance Health's revenue for the twelve months ending Sep 30, 2026 was $201.83B, up 3.6% year over year. For fiscal 2025 it was $199.13B, up 12.5% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $199.13B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$199.13B+12.5%
FY2024Dec 31, 2024$177.01B+3.3%
FY2023Dec 31, 2023$171.34B+9.4%
FY2022Dec 31, 2022$156.60B+13.0%
FY2021Dec 31, 2021$138.64B+13.8%
FY2020Dec 31, 2020$121.87B+16.9%
FY2019Dec 31, 2019$104.21B+13.1%
FY2018Dec 31, 2018$92.11B+2.3%
FY2017Dec 31, 2017$90.04B+6.1%
FY2016Dec 31, 2016$84.86B+7.2%
FY2015Dec 31, 2015$79.16B+7.2%
FY2014Dec 31, 2014$73.87B+4.0%
FY2013Dec 31, 2013$71.02B+15.5%
FY2012Dec 31, 2012$61.50B+1.3%
FY2011Dec 31, 2011$60.71B+3.4%
FY2010Dec 31, 2010$58.70B-9.6%
FY2009Dec 31, 2009$64.94B+6.0%
FY2008Dec 31, 2008$61.25B+0.1%
FY2007Dec 31, 2007$61.17B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$51.43B+1.4%
Q2 FY2026Jun 30, 2026$50.47B+1.4%
Q1 FY2026Mar 31, 2026$50.18B+2.6%
Q4 FY2025Dec 31, 2025$49.75B+9.5%
Q3 FY2025Sep 30, 2025$50.71B+12.4%
Q2 FY2025Jun 30, 2025$49.78B+13.4%
Q1 FY2025Mar 31, 2025$48.89B+14.8%
Q4 FY2024Dec 31, 2024$45.44B+6.6%
Q3 FY2024Sep 30, 2024$45.11B+5.3%
Q2 FY2024Jun 30, 2024$43.89B+0.5%
Q1 FY2024Mar 31, 2024$42.58B+1.0%
Q4 FY2023Dec 31, 2023$42.65B+6.8%
Q3 FY2023Sep 30, 2023$42.85B+7.3%
Q2 FY2023Jun 30, 2023$43.67B+13.0%
Q1 FY2023Mar 31, 2023$42.17B+10.7%
Q4 FY2022Dec 31, 2022$39.93B+9.2%
Q3 FY2022Sep 30, 2022$39.94B+11.5%
Q2 FY2022Jun 30, 2022$38.63B+14.1%
Q1 FY2022Mar 31, 2022$38.10B+17.6%
Q4 FY2021Dec 31, 2021$36.58B+14.9%
Q3 FY2021Sep 30, 2021$35.82B+15.0%
Q2 FY2021Jun 30, 2021$33.85B+15.7%
Q1 FY2021Mar 31, 2021$32.39B+9.3%
Q4 FY2020Dec 31, 2020$31.82B+16.1%
Q3 FY2020Sep 30, 2020$31.16B+16.8%
Q2 FY2020Jun 30, 2020$29.26B+14.9%
Q1 FY2020Mar 31, 2020$29.62B+20.1%
Q4 FY2019Dec 31, 2019$27.41B+17.3%
Q3 FY2019Sep 30, 2019$26.67B+14.7%
Q2 FY2019Jun 30, 2019$25.47B+11.0%
Q1 FY2019Mar 31, 2019$24.67B+9.4%
Q4 FY2018Dec 31, 2018$23.37B+3.0%
Q3 FY2018Sep 30, 2018$23.25B+3.7%
Q2 FY2018Jun 30, 2018$22.94B+2.4%
Q1 FY2018Mar 31, 2018$22.54B+0.1%
Q4 FY2017Dec 31, 2017$22.68B+4.5%
Q3 FY2017Sep 30, 2017$22.43B–
Q2 FY2017Jun 30, 2017$22.41B–
Q1 FY2017Mar 31, 2017$22.53B–
Q4 FY2016Dec 31, 2016$21.71B–

More Elevance Health figures

See a number that looks wrong?